Effects of Vitamin D and Omega-3 Fatty Acids on Infectious Diseases and hCAP18 [ANCILLARY OF 700049031]
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 15 Feb 2016
At a glance
- Drugs Colecalciferol (Primary) ; Omega-3-acid ethyl esters (Primary)
- Indications Bacterial infections; Viral infections
- Focus Therapeutic Use
- Acronyms VITAL-Infection
- 08 Apr 2014 Planned End Date changed from 1 Jun 2016 to 1 Oct 2017 as reported by Clinicaltrials.gov record.
- 08 Apr 2014 Status changed from recruiting to active, no longer recruiting as reported by Clinicaltrials.gov record.
- 17 Feb 2013 New trial record